Home » Topics » Regulatory » Patents

Patents
RSS

Stanford and Washington University present immunoconjugates including chemerin

Aug. 9, 2017

Shanghai Hengrui, Jiangsu Hengrui Medicine describe new anti-PCSK9 antibodies

Aug. 9, 2017

Biogen describes novel IRAK-4 inhibitors

Aug. 9, 2017

GlaxoSmithKline patents HIV maturation inhibitors

Aug. 9, 2017

Prospero Pharmaceuticals divulges agents for pantothenate kinase-associated neurodegeneration

Aug. 7, 2017

Janssen R&D Ireland presents novel anti-influenza compounds

Aug. 7, 2017

Boehringer Ingelheim patents nuclear receptor RORgamma antagonists

Aug. 7, 2017

Ningbo Wenda describes novel bromodomain-containing protein 4 inhibitors

Aug. 7, 2017

Sichuan Haisco Pharmaceutical divulges new antivirals

Aug. 4, 2017

Janssen Pharmaceutica identifies MAP3K14 inhibitors

Aug. 4, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...